Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude miceJörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn, et al.EJNMMI Physics|October 27, 2015
Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneityJonas Högberg, Magnus Rizell, Ragnar Hultborn, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Intraperitoneal alpha-radioimmunotherapy in mice using different specific activitiesJörgen Elgqvist, Håkan Andersson, Elin Haglund, et al.Cancers|May 25, 2024
Ex Vivo Vascular Imaging and Perfusion Studies of Normal Kidney and Tumor VasculatureRagnar Hultborn, Lilian Weiss, Egil Tveit, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivoTom Bäck, Håkan Andersson, Chaitanya R Divgi, et al.Translational Oncology|September 28, 2020
Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancerStig Palm, Tom Bäck, Emma Aneheim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor modelHåkan Andersson, Jörgen Elgqvist, György Horvath, et al.International Journal of Radiation Biology|November 9, 2012
Differential gene expression in human fibroblasts after alpha-particle emitter (211)At compared with (60)Co irradiationAnna Danielsson, Kristina Claesson, Toshima Z Parris, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35Jörgen Elgqvist, Håkan Andersson, Tom Bäck, et al.Acta Oncologica (Stockholm, Sweden)|July 26, 2006
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancerKenneth Villman, Johanna Sjöström, Reino Heikkilä, et al.Pageof 5